Skip to content

ESD Home

TechCentury

Powered by

Engineering Society of Detroit Lawrence Technological University

Tag: Millendo Therapeutics

Clinical Trials / Pharmaceuticals

Millendo Starts New Trial On Polycystic Ovary Syndrome Drug

ANN ARBOR — The pharma startup Millendo Therapeutics Inc. announced the start of a Phase 2b clinical trial to assess the efficacy of drug candidate MLE4901, a non-hormonal therapy for …

Pharmaceuticals

Ann Arbor Pharma Reports Good News From Clinical Trial

ANN ARBOR — A new drug to treat polycystic ovary syndrome got good results in a Phase 2a clinical trial, according to the drug’s developer, Millendo Therapeutics Inc. of Ann …

Pharmaceuticals

Ann Arbor Pharma Firm Gets $62M To Commercialize Drug For Ovarian Disease

ANN ARBOR — Millendo Therapeutics Inc., the Ann Arbor pharma firm, announced an exclusive license agreement with the pharmaceutical giant AstraZeneca for the worldwide development and commercialization rights to AZD4901, …

Posts navigation

Newer posts

Read the magazine:

TechCentury
Advertise or Contribute an Article
Lawrence Technological University

Subscribe to TechCentury.com

Top Posts

  • Meijer adds 'Shop & Scan' technology
  • Liquid Web Bought Out By Chicago Firm; Founding CEO To Step Down
  • ESD Spring Engineering & Tech Job Fair Drawing A Big Crowd
  • Presentations sought for INCOSE conference
  • Kraig Biocraft shareholders OK reverse stock split, uplisting to national exchange

Archives

Follow Us On

© The Engineering Society of Detroit   |   ABOUT